These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15150727)

  • 1. Evaluation of porfimer sodium in dogs and cats with spontaneous tumors.
    Gloi AM; Beck E
    Vet Ther; 2004; 5(1):26-33. PubMed ID: 15150727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence detection of a new photosensitizer, PAD-S31, in tumour tissues and its use as a photodynamic treatment for skin tumours in dogs and a cat: a preliminary report.
    Tanabe S; Yamaguchi M; Iijima M; Nakajima S; Sakata I; Miyaki S; Takemura T; Furuoka H; Kobayashi Y; Matsui T; Uzuka Y; Sarashina T
    Vet J; 2004 May; 167(3):286-93. PubMed ID: 15080878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Threshold dose of three photosensitizers in dogs with spontaneous tumors.
    Gloi AM; Beck E
    Vet Ther; 2003; 4(3):269-78. PubMed ID: 15136988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution of three photosensitizers in dogs with spontaneous tumors.
    Gloi AM; Beck E
    Vet Ther; 2003; 4(2):155-65. PubMed ID: 14506591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study on light dosimetry variables for photodynamic therapy of Barrett's esophagus with high-grade dysplasia.
    Gill KR; Wolfsen HC; Preyer NW; Scott MV; Gross SA; Wallace MB; Jones LR
    Clin Cancer Res; 2009 Mar; 15(5):1830-6. PubMed ID: 19240171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy of naturally occurring tumors in animals using a novel benzophenothiazine photosensitizer.
    Frimberger AE; Moore AS; Cincotta L; Cotter SM; Foley JW
    Clin Cancer Res; 1998 Sep; 4(9):2207-18. PubMed ID: 9748141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dose ranging study of photodynamic therapy with porfimer sodium (Photofrin) for treatment of basal cell carcinoma.
    Oseroff AR; Blumenson LR; Wilson BD; Mang TS; Bellnier DA; Parsons JC; Frawley N; Cooper M; Zeitouni N; Dougherty TJ
    Lasers Surg Med; 2006 Jun; 38(5):417-26. PubMed ID: 16788928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Veterinary photodynamic therapy: a review.
    Buchholz J; Walt H
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):342-7. PubMed ID: 24284083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porfimer: new drug. Endobrachyesophagus: encouraging preliminary results.
    Prescrire Int; 2006 Apr; 15(82):58-9. PubMed ID: 16604738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of effect of sex and disease state on the pharmacokinetics of porfimer sodium.
    Houle JM; Clervoix N; Bain S; Spénard J
    Clin Pharmacokinet; 2006; 45(9):923-30. PubMed ID: 16928153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodular basal cell carcinoma in Gorlin's syndrome treated with systemic photodynamic therapy and interstitial optical fiber diffuser laser.
    Madan V; Loncaster JA; Allan D; Lear JT; Sheridan L; Leach C; Allan E
    J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S86-9. PubMed ID: 17052541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy for gastrointestinal disease.
    Petersen BT; Chuttani R; Croffie J; DiSario J; Liu J; Mishkin D; Shah R; Somogyi L; Tierney W; Wong Kee Song LM
    Gastrointest Endosc; 2006 Jun; 63(7):927-32. PubMed ID: 16733105
    [No Abstract]   [Full Text] [Related]  

  • 13. [Porfimer sodium (Photofrin-II)].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1995 Aug; 22(9):1271-8. PubMed ID: 7661580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy for nasal and aural squamous cell carcinoma in cats.
    Peaston AE; Leach MW; Higgins RJ
    J Am Vet Med Assoc; 1993 Apr; 202(8):1261-5. PubMed ID: 8496082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary evaluation of bleomycin in feline and canine squamous cell carcinoma.
    Buhles WC; Theilen GH
    Am J Vet Res; 1973 Feb; 34(2):289-91. PubMed ID: 4119568
    [No Abstract]   [Full Text] [Related]  

  • 16. The pharmacokinetics and safety of porfimer after repeated administration 30-45 days apart to patients undergoing photodynamic therapy.
    Pereira SP; Ayaru L; Ackroyd R; Mitton D; Fullarton G; Zammit M; Grzebieniak Z; Messmann H; Ortner MA; Gao L; Trinh MM; Spénard J
    Aliment Pharmacol Ther; 2010 Sep; 32(6):821-7. PubMed ID: 20629974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing photodynamic therapy: in vivo pharmacokinetics of liposomal meta-(tetrahydroxyphenyl)chlorin in feline squamous cell carcinoma.
    Buchholz J; Kaser-Hotz B; Khan T; Rohrer Bley C; Melzer K; Schwendener RA; Roos M; Walt H
    Clin Cancer Res; 2005 Oct; 11(20):7538-44. PubMed ID: 16243829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porfimer Sodium Versus PS785 for Photodynamic Therapy (PDT) of Lung Cancer Xenografts in Mice.
    Nwogu C; Kloc A; Attwood K; Bshara W; Durrani F; Pandey R
    J Surg Res; 2021 Jul; 263():245-250. PubMed ID: 33713956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo photosensitizing applications of Photofrin in malignant melanoma cells.
    Chang CJ; Yu JS; Wei FC
    Chang Gung Med J; 2008; 31(3):260-7. PubMed ID: 18782948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photofrin photodynamic therapy: 2.0 mg/kg or not 2.0 mg/kg that is the question.
    Allison RR; Sibata CH
    Photodiagnosis Photodyn Ther; 2008 Jun; 5(2):112-9. PubMed ID: 19356641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.